BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 23, 2011
View Archived Issues
CalciMedica begins phase I trial of CM-2489 for psoriasis
Read More
FDA grants orphan drug status to MGN-4893 in polycythemia vera
Read More
Phase I/II trial of panobinostat/bicalutamide combination in prostate cancer advances
Read More
IST5-002 shows promise in models of prostate cancer
Read More
MedTrust Online and Avantra partner to validate cancer biomarker assays
Read More
Brusatol suppresses development of resistance to chemotherapeutic agents in vivo
Read More
Gelsolin is a putative biomarker in subarachnoid hemorrhage
Read More
Fractalkine is a potential target for drugs for Parkinson's disease
Read More
TB Alliance presents agents for tuberculosis and protozoal infections
Read More
Kancera acquires iNovacia
Read More
Omeros expands exclusive PDE7 inhibitor license from Daiichi Sankyo
Read More
Infinity Pharma begins phase II portion of IPI-926 trial in pancreatic cancer
Read More
IRM discloses new GPR119 receptor modulators
Read More
Regeneron submits BLA for VEGF Trap-Eye for wet AMD
Read More
Merck & Co. claims new activators of glycoprotein hormone FSH receptor
Read More
Angiochem receives NBTS innovation award for development of new brain cancer treatments
Read More
Kyowa Hakko Kirin to acquire ProStrakan
Read More
Encouraging phase IIa data reported on Cx-601 for perianal fistulas in patients with Crohn's disease
Read More
GSK presents novel GlyT1 inhibitors
Read More
AstraZeneca and Pulmagen present dual-acting agents for respiratory disorders
Read More
Gilead Sciences to acquire Calistoga Pharmaceuticals
Read More
Sanofi Pasteur and International Vaccine Institute join forces against dengue fever
Read More
Chugai's anticancer agent Xeloda approved for additional indication in Japan
Read More
Theratechnologies to launch new clinical program for tesamorelin in COPD-associated muscle wasting
Read More
Forest Labs enters into definitive merger agreement to acquire Clinical Data
Read More